# Sarepta Therapeutics, Inc.: Form 8-K, filed Jan 13, 2020

- Company: [Sarepta Therapeutics, Inc.](/companies/srpt.md) (CIK 873303)
- Form: 8-K
- Filed: 2020-01-13
- Accepted by EDGAR: Jan 13, 2020, 08:41 ET
- Period: 2020-01-08
- Accession: 0001564590-20-000918
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/873303/000156459020000918/srpt-8k_20200108.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/873303/000156459020000918/

## Items reported

- Item 2.02: Results of operations
- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/873303/000156459020000918/srpt-8k_20200108.htm

Filed Jan 13, 2020.
Source: SEC EDGAR, the filing index for accession 0001564590-20-000918. Last ingested by Listed: Nov 14, 2026, 19:58 ET. No prices; not investment advice.
